Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.9% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04950959Recruiting

XACT ACE Observational Registry

Role: lead

NCT03008603Not ApplicableCompleted

Evaluation of the Safety, Effectiveness & Usability of the XACT Robotic System for Image Guided Percutaneous Procedures

Role: lead

NCT04651517Not ApplicableCompleted

Pilot Study of the ACE System in Lung Procedures

Role: lead

NCT04612985Not ApplicableWithdrawn

Evaluation of the XACT Robotic System for Image-guided Percutaneous Lung Procedures

Role: lead

All 4 trials loaded